Výsledky vyhledávání - "William Abramovits"

Spesolimab, an anti-interleukin-36 receptor antibody, in patients with moderate-to-severe atopic dermatitis: results from a multicenter, randomized, double-blind, placebo-controlled, phase IIa study

Autor: Robert Bissonnette, William Abramovits, Étienne Saint‐Cyr Proulx, Patricia Lee, Emma Guttman‐Yassky, Elizabeta Zovko, Ralf Sigmund, Joanne Willcox, Thomas Bieber

Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV.

Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disease, and there is increasing evidence that the interleukin (IL)-36 pathway may play a role in the pathogenesis of AD.To evaluate the efficacy and safety of spesolimab, a novel anti-I

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a67df65d2662a91207f16ce6004c7ac2
https://pubmed.ncbi.nlm.nih.gov/36376738

Zobrazit plný text záznamu

Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents

Autor: Robert Sidbury, Sady Alpizar, Vivian Laquer, Sunil Dhawan, William Abramovits, Luca Loprete, Jayendar Kumar Krishnaswamy, Faiz Ahmad, Zarif Jabbar-Lopez, Christophe Piketty

Publikováno v: Dermatology and therapy. 12(3)

Nemolizumab, a new monoclonal antibody that targets the receptor alpha of the neuroimmune cytokine interleukin-31 (IL-31), has shown efficacy in atopic dermatitis (AD) in adults. This study evaluated the pharmacokinetics (PK) and safety of nemolizuma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bdbb2f53433fb89469f114318ba9626
https://pubmed.ncbi.nlm.nih.gov/35088348

Zobrazit plný text záznamu

JUBLIA (Efinaconazole 10% Solution) in the Treatment of Pediatric Onychomycosis

Autor: Aditya K, Gupta, Maanasa, Venkataraman, William, Abramovits, Eric P, Guenin

Publikováno v: Skinmed. 19(3)

Onychomycosis is a chronic fungal infection of the nails and is commonly observed in adults, especially the elderly, those who are diabetic, have poor peripheral circulation, and are immunocompromised; however, onychomycosis in children is being repo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3f88135993e58948ffc1f396d3df1c95
https://pubmed.ncbi.nlm.nih.gov/34303391

Zobrazit plný text záznamu

Conceptual Model to Illustrate the Symptom Experience and Humanistic Burden Associated With Atopic Dermatitis in Adults and Adolescents

Autor: Rob Arbuckle, Lotte Seiding Larsen, Eric L. Simpson, William Abramovits, Jonathan I. Silverberg, Nana Kragh, Laura Grant, Julie Hahn-Pedersen, Jean-François Stalder, Jean Paty, Bo Bang, Claire Trennery

Publikováno v: Dermatitis

Supplemental digital content is available in the text.
Atopic dermatitis (AD) is a pruritic or painful dermatologic disease characterized by xerosis and eczema lesions. The symptoms/signs of AD can significantly impact patients' health-related q

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8b592f7506ed4b747feecc47c5b9748
https://doi.org/10.1097/der.0000000000000486

Zobrazit plný text záznamu

Efficacy and Safety of Systemic Treatments for Skin and Joint Manifestations in Patients With Psoriasis

Autor: William, Abramovits, Joel, Schlessinger

Publikováno v: Journal of drugs in dermatology : JDD. 19(3)

Psoriasis is a chronic, systemic disease with features suggestive of autoimmune dysregulation. Patients with psoriasis vulgaris frequently experience systemic comorbidities, including cardiovascular and metabolic diseases, and approximately 30% devel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f7189372155093c0a7571fc5da46436c
https://pubmed.ncbi.nlm.nih.gov/32550687

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání